You may post the U Michigan info. Our rate has stayed at 15%. Noone has mentioned the fact that discrepancies across the country in health care costs may mean that it is more expensive to conduct trials in some locations regardless of the indirect. Health care is relatively expensive in Michigan so that even at 15% tdc of indirect we find it hard to match some of the per patient costs some other institutions find acceptable. To increase the indirect only to be forced to discount the direct to stay competitive would be counterproductive. The idc issue for clincial trials is more complex than joining together to hold the line to a particular number. Elaine Brock U Michigan p (313) 764-7250 f (313) 763-4053 xxxxxx@umich.edu From: Research Administration Discussion Group on Thu, Aug 22, 1996 7:41 PM >These are the results of a survey I conducted on this list a couple of years >ago. I don't know if the results are still valid. The rate for UCONN >Health Center is still as it was 2 years ago. > >Indirect Cost Rates for Clinical Trials - (UCHC Survey) > >INSTITUTION RATE COMMENTS > >Albert Einstein Medical Center 20.0% >Baylor University 20.0% (minimum, rate negotiated for each > trial) >East Tennessee State University 22.0% >Eastern Virginia Medical School 20.0% >Emory University 20.0% >Evanston Hospital > (Affiliate of Northwestern Univ.) 35.0% >Indiana University School of Medicine 25.0% >Jefferson Medical College > (Thomas Jefferson Univ.) 25.0% >Medical College of Ohio 25.0% >Northwestern University 35.0% >Ohio State University 12.0% >Rehab. Institute of Chgo. > (Affil. of Northwestern Univ.) 25.0% >Southern Illinois University > School of Medicine 25.0% >Stanford University 31.0% (if no int. prop. terms) >Tulane University Medical Center 25.0% (for new contracts) >University of Arizona 20.0% (human subjects only) >University of Calgary 25.0% >University of California, Irvine 20.7% >University of California, Los Angeles 22.5% >University of California, San Diego 19.5% >University of California, San Francisco26.0% (off-campus, h.s. only) >University of California, San Francisco29.5% (on-campus, h.s. only) >University of Colorado > Health Sciences Center 26.0% >University of Connecticut > Health Center 26.0% >University of Illinois 25.0% >University of Maryland at Baltimore 20.0% >University of Massachusetts > Medical Center 25.0% >University of Michigan 15.0% >University of Missouri 23.0% >University of Rochester 25.0% >University of Wisconsin 20.0% >William Beaumont > Hospital, Royal Oak, MI 15.0% >Yale University 30.0% > >MEAN = 23.6% >STD DEV = 5.0% >VAR = 0.3% >MEDIAN = 25.0% > >The University of Michigan conducted a similar survey a year or two earlier >than mine. I have a copy, but I can't recall if they gave me permission to >post the information. If some one from UM confirms its OK to post it, I >will, or perhaps they have updated theirs, and can post it. It would be >useful to update this information, and if anyone cares to respond directly >to me, I will do so and post it in a few weeks. We at UCONN have found this >information of great value. > >Len Paplauskas >Asst. VP for Research >UCONN Health Center >Farmington, CT 06030-5355 >860-679-3173 (voice) >860-679-2670 (fax) >xxxxxx@adp.uchc.edu > > ---------- >From: Research Administration Discuss >To: Multiple recipients of list RES >Subject: Clinical Study IDC Rates >Date: Wednesday, August 21, 1996 1:28PM > >Dear Colleagues- > >The indirect cost rate for clincial studies at the University of >Florida is 25% of total direct costs. What are the rates applied to >clinical studies at some of your institutions? Please indicate what >base is used. Thanks for your help. If there is interest I can post >results to whoever is interested. Thanks. >******************************************************************** > > >Thomas J. Roberts, Assistant Director for Research >University of Florida, College of Medicine >Phone (904) 392-5398, Fax (904) 392-7427 >e-mail "xxxxxx@dean.med.ufl.edu" > >------------------ RFC822 Header Follows ------------------ >Received: by mail3.drda.umich.edu with ADMIN;22 Aug 1996 19:41:03 -0400 >Received: by twins.rs.itd.umich.edu (8.7.5/2.2) > with X.500 id TAA07672; Thu, 22 Aug 1996 19:34:20 -0400 (EDT) >Received: from gate1.health.state.ny.us by twins.rs.itd.umich.edu (8.7.5/2.2) > with SMTP id TAA07663; Thu, 22 Aug 1996 19:34:19 -0400 (EDT) >Received: by gate1.health.state.ny.us id AA23947 > (InterLock SMTP Gateway 3.0 for xxxxxx@UMICH.EDU); > Thu, 22 Aug 1996 18:09:33 -0400 >Message-Id: <xxxxxx@gate1.health.state.ny.us> >Received: by gate1.health.state.ny.us (Internal Mail Agent-2); > Thu, 22 Aug 1996 18:09:33 -0400 >Received: by gate1.health.state.ny.us (Internal Mail Agent-1); > Thu, 22 Aug 1996 18:09:33 -0400 >Date: Thu, 22 Aug 1996 09:22:33 -0400 >Reply-To: Research Administration Discussion Group > <xxxxxx@health.state.ny.us> >Sender: Research Administration Discussion Group > <xxxxxx@health.state.ny.us> >From: Research Administration Discussion Group > <xxxxxx@health.state.ny.us> >X-From: "Paplauskas,Leonard" <xxxxxx@ADP.UCHC.EDU> >Organization: UConn Health Center, 263 Farmington Ave, Farmington CT, USA >Subject: Re: Clinical Study IDC Rates >X-To: Research Administration Discuss > <xxxxxx@albnydh2.health.state.ny.us> >To: Multiple recipients of list RESADM-L ><xxxxxx@health.state.ny.us>
